Which returned more over the last year, IBB or SHV?

In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and SHV returned +3.6%, so IBB returned more. One year is one year; the longer windows are in the table.

Which is cheaper, IBB or SHV?

IBB charges 0.44% a year and SHV charges 0.15%, so SHV is cheaper. Fees come from each fund's prospectus.

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

IBB vs SHV: how they differ

IBB and SHV hold 0% of their weight in the same names, and IBB returned more over the year.

iShares Biotechnology ETF and iShares 0-1 Year Treasury Bond ETF.

What they hold in common

By the books each fund has filed, IBB and SHV hold 0% of their money in the same securities at the same weight.

Largest positions each one holds and the other does not
Only in IBB	Only in SHV
Vertex Pharmaceuticals, Inc. 8.09%	United States of America 17.17%
Amgen, Inc. 7.84%	United States of America 12.38%
Gilead Sciences, Inc. 6.85%	United States of America 9.88%
Regeneron Pharmaceuticals, Inc. 4.91%	United States of America 8.60%
Argenx SE 3.76%	United States of America 8.55%
Alnylam Pharmaceuticals, Inc. 3.12%	United States of America 8.38%
Natera, Inc. 2.89%	United States of America 6.85%
Revolution Medicines, Inc. 2.78%	United States of America 6.81%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.

IBB and SHV on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
	IBB iShares Biotechnology ETF	SHV iShares 0-1 Year Treasury Bond ETF
Where it sits	Core index fund	Core index fund
Issuer	iShares	iShares
What it is	Biotechnology	0-1 Year Treasury Bond
Total return, 1 year	+41.5%	+3.6%
S&P 500 over the same days	+17.5%	+17.5%
Gap to the S&P 500	+24.0 pts	−13.9 pts
Expense ratio	0.44%	0.15%
Holdings	248	13

IBB in plain words

IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 248 positions, with the top ten at 44.8%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.

SHV in plain words

SHV is a bond fund tracking the 0-1 Year Treasury Bond. Over the year to Sep 11, 2026 it returned +3.6% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.15% a year.

Questions people ask

Which returned more over the last year, IBB or SHV?: In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and SHV returned +3.6%, so IBB returned more. One year is one year; the longer windows are in the table.
Which is cheaper, IBB or SHV?: IBB charges 0.44% a year and SHV charges 0.15%, so SHV is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

IBB against SHV, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, IBB against SHV, data as of Sep 12, 2026. https://etfiq.com/compare/any/IBB-SHV Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources